Infectious disease antibodies for research and diagnostic assay development

17 Dec 2021

In this application note, Merck highlights its infectious disease portfolio that features over 200 high-quality antibodies covering over 40 disease areas, and backed by extensive technical expertise to support immunoassay development.

Links

Tags